Navigation Links
Amyotrophic in Medical News

Stem Cells Could Slacken the Pace of Amyotrophic Lateral Sclerosis Disease, Study

United States researchers have explained the recent improvements in the treatment of amyotrophic lateral sclerosis (ALS), which is capable of slowing// the onset of paralysis. It is observed that people with the disease die a slow death when the muscles in charge of breathing actually stop working....

Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis

Researchers from the University of California, San Diego (UCSD) School of Medicine, the Center for Neurologic Study and Isis Pharmaceutical Corporation have created// and tested molecular therapy in animals which they feel will assist in the treatment of amyotrophic lateral sclerosis (ALS), or Lou ...

iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board

...artners, MPM Capital and FinTech Global Capital. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute ...

Bally Total Fitness Flexes Fundraising Muscle to Fight ALS

... Augie's Quest , MDA's fast-track ALS research initiative, is an aggressive, cure-driven effort singularly focused on finding treatments and cures for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). For more information on Augie's Quest or to make a donation, please visit www.augiesquest.org or ...

Insmed Provides Update on Supply of IPLEX(TM)

... and the remainder around the rest of the world. Most of the patients receive IPLEX(TM) pursuant to a court-ordered Extended Access Program (EAP) for amyotrophic Lateral Sclerosis (ALS) in Italy. The 12 U.S. patients are being treated for ALS under single patient Investigational New Drug applications approved ...

Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business

... center designed to advance the research, early detection and treatment of neurological diseases, including Alzheimer's, Huntington's, Parkinson's and amyotrophic Lateral Sclerosis (ALS). "We still have much more to accomplish, but welcoming patients and caregivers is a truly significant benchmark for...

DynaVox Systems LLC Merges with Blink Twice

... gives a voice to the millions of people who are unable to use speech as their primary means of communication due to the effects of conditions such as amyotrophic lateral sclerosis (ALS or Lou Gehrig's Disease), stroke, traumatic brain injury, cerebral palsy, Parkinson's Disease, autism and mental retardation. ...

Growth Hormone May Build Muscle in Older Men

... in Glasgow, Scotland. The growth hormone may also benefit patients who can't do intensive exercise because of diseases such as muscular dystrophy, amyotrophic lateral sclerosis (ALS), kidney disease or cancer. MGF may even help slow muscle loss among astronauts who spend long hours in zero gravity during spa...

Finding Raises Hope for Treating ALS

...et and symptoms could be targeted for therapy, study suggests,, MONDAY, JUNE 15 (HealthDay News) -- Researchers now believe that ALS, or amyotrophic lateral sclerosis, starts well before its debilitating symptoms appear, a finding that they say could eventually lead to an effective treatment. P...

New Jefferson study may redefine how a chronic auto-immune disease is diagnosed

...diagnostic Neuromuscular Lab at JHN, led the study which looked at the number of demyelinating features that are needed to differentiate between CIDP, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and diabetic neuropathy. His research suggests a minimum number of three demyelinating features can ...
Amyotrophic in Medical Technology

AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis

LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited ( http://www.davalinternational.com ) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded Orphan Status for ...

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)

SB-509 to be Evaluated in Repeat-Dosing Study in Subjects with ALS RICHMOND, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has opened a Phase 2 clinical trial (SB-509-801) to evaluate its drug, SB-509, in subjects with ALS, a pr...

Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis

Company Received $5.2 Million in Cost Recovery from EAP in 2007 RICHMOND, Va., Jan. 24 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today provided an update on the IPLEX(TM) Expanded Access Program (EAP) in Italy for the t...

Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Selected Therapy Can Advance to Phase III Clinical Trial PALO ALTO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, today announ...

Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND

PALO ALTO, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that data related to the Company's Amyotrophic Lateral Scler...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and amyotrophic Lateral Sclerosis (ALS). The Company filed an IND (Investigational New Drug) application with the FDA for ALS clinical trials in December, 2008, and h...

Neuralstem's ALS Trial on Clinical Hold

... by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and amyotrophic Lateral Sclerosis (ALS). In pre-clinical work, the company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported th...

Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives

...factor (VEGF) with three Phase 2 clinical trials ongoing for the treatment of diabetic neuropathy (DN) and one to evaluate its use in the treatment of amyotrophic lateral sclerosis (ALS). We have also advanced our preclinical pipeline and expect to file Investigational New Drug (IND) application for the first of...

ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease

...ndentify the altered expression of genes and proteins, at the onset of, and throughout the progression of the fatal neurodegenerative disease known as amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease). The knowledge generated through this effort will be crucial to the identification of ...

Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications

...To read the stories of successfully implanted patients, visit http://www.synapsebiomedical.com/news/success/ . ALS Clinical Trials Also Underway amyotrophic Lateral Sclerosis (ALS), commonly referred to as Lou Gehrig's disease, is a rapidly progressing, incurable and fatal neuromuscular disease characteriz...
Amyotrophic in Medical Definition

Proteopathy

...Synuclein Tauopathies (multiple) Microtubule-associated protein tau Frontotemporal lobar degeneration (FTLD) (Ubi+, Tau-) TDP-43 amyotrophic lateral sclerosis (ALS) Superoxide dismutase, TDP-43 Huntington's disease and other triplet repeat disorders (multiple) Proteins with tandem...
Amyotrophic in Medical Dictionary

Amyotrophic lateral sclerosis

... amyotrophic lateral sclerosis is a form of motor neuron ... the central nervous system that control... amyotrophic lateral sclerosis (ALS) — Comprehensive overv... of this degenerative neurological condition. amyotrophic lateral sclerosis (ALS), also known as Lou Ge...

ALS

... Hyperlinked overview of amyotrophic lateral sclerosis ( ALS ) with symptoms, dia...tudies/potential treatments for ALS , or ... amyotrophic lateral sclerosis ( ALS ), also known as Lou Ge...mation, articles, clinical trials, and more about amyotrophic lateral sclerosis for both patients and health ...
Amyotrophic in Biological News

UMMS researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis

WORCESTER, Mass. A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD...

'Show me the money!' MDA greenlights grants

...ded has created the basis for progressive treatments of muscular dystrophy, amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, and spinal muscular atrop...r three years to study how defects in the blood-brain barrier contribute to amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. Ilieva hopes to find a wa...

Brain-computer interface, developed at Brown, begins new clinical trial

...ial is part of a larger BrainGate research effort, the ultimate goal of which is to help patients with spinal cord injury, stroke, muscular dystrophy, amyotrophic lateral sclerosis (ALS) or limb loss turn their thoughts into actions, restoring independence, mobility, and communication. The work to date with Brai...

Brain protein central to both Parkinson's, drug addiction identified

... electrical signals. Astrocytes' role in Parkinson's is no surprise to brain experts who have also identified them as a player in Alzheimer's disease, amyotrophic lateral sclerosis, epilepsy, and other diseases. "Astrocytes are definitely much more than support cells in the brain," said Kim Tieu, Ph.D., a cor...

New light on bipolar treatment drugs

...thium could become very important over the next few years." Lithium is currently under clinical trial for the treatment of neurogenerative disorder amyotrophic lateral sclerosis (ALS) The research, funded by the Wellcome Trust, is published in the journal Disease Models and Mechanisms . ...

Researchers use brain interface to post to Twitter

...wide who aim to perfect a communication system for users whose bodies do not work, but whose brains function normally. Among those are people who have amyotrophic lateral sclerosis (ALS), brain-stem stroke or high spinal cord injury. Some brain-computer interface systems employ an electrode-studded cap wired ...

Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease

...f ALS. The study, entitled Caffeine Reduces Motor Performance and Antioxidant Enzyme Capacity in the Brain of Female G93A Mice, An Animal Model of amyotrophic Lateral Sclerosis (ALS) was conducted by Rajini Seevaratnam1 supervised by Mazen J. Hamadeh1,2 , and co-authored by Sandeep Raha2 and Mark A. Tarnopol...

Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease

...f ALS. The study, entitled Caffeine Reduces Motor Performance and Antioxidant Enzyme Capacity in the Brain of Female G93A Mice, An Animal Model of amyotrophic Lateral Sclerosis (ALS) was conducted by Rajini Seevaratnam1 supervised by Mazen J. Hamadeh1,2 , and co-authored by Sandeep Raha2 and Mark A. Tarnopol...

Jefferson researcher awarded Landenberger Foundation grant for ALS research

...s Jefferson University was recently awarded a Margaret Q. Landenberger Research Foundation grant to identify why drug therapies that showed promise in amyotrophic Lateral Sclerosis (ALS) mouse models have proven unsuccessful in human clinical trials. Dr. Pasinelli and her research team will closely examine crit...

Blood test predicts chance of dementia

...D. New results indicate that progranulin also plays a role in the death of brain cells in other diseases of the brain, such as Alzheimer's disease and amyotrophic Lateral Sclerosis (ALS). Predictive test On the basis of their research, Kristel Sleegers, a scientist in Van Broeckhoven's team, has develope...
Amyotrophic in Biological Technology

iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming

...rtners, MPM Capital and FinTech Global Capital. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute ...

Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th

...ute (ALS TDI). Corey will attend both baseball games to raise awareness of amyotrophic lateral scleroses (ALS, Lou Gehrig's disease) a neurodegenerative disease o... Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focuse...

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

...d, "IPLEX(TM) continues to demonstrate a strong safety profile and we believe it offers a potential treatment in multiple therapeutic areas, including amyotrophic Lateral Sclerosis. Beyond IPLEX(TM), our current cash reserves of approximately $120 million provides us with a significant opportunity to continue g...

iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

...cal needs. We will look to Dr. Goodman's extensive knowledge and leadership in neurology to help advance our proprietary neurodegenerative programs in amyotrophic lateral sclerosis, spinal muscular atrophy and Parkinson's disease," said John P. Walker, chief executive officer of iZumi. "Over the next few months,...

Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States

...mlb.com . About ALS TDI The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust disc...

Insmed Announces First Quarter 2009 Financial Results

...cond quarter of 2009; The FDA announced that it would allow Insmed to provide access to IPLEX(TM) for investigational use in patients with amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease). Insmed will conduct a controlled clinical trial under an Investigational New Drug application; ...

iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development

...aufield and Byers and Highland Capital Partners. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iZumi has a collaboration with The Gladstone Institute of ...

ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer

...ve therapeutic development effort in the world focused entirely on stopping amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease). ALS is a progressive neurode... Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible. Focused...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.

...t candidate of this therapeutic platform is a spinal cord cell line. When implanted into animal models, the cells have extended the lives of rats with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and reversed paralysis in ischemic spastic paraplegia models. In December 2008, Neuralstem filed an In...

Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)

...agreement, Insmed will continue to be responsible for the IPLEX(TM) EAP for amyotrophic Lateral Sclerosis (ALS) in Italy, as well as all IPLEX(TM)-related activiti...PLEX(TM) to patients that are suffering from debilitating diseases, such as amyotrophic Lateral Sclerosis, and have no other medical options," said Dr. Geoffrey Al...
Amyotrophic in Biological Products

Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals

Description:... Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
Company:Novus Biologicals
Other Tags
(Date:12/26/2014)... Parker & Sons, Inc. a reliable ... cooling and plumbing contractor services throughout Arizona announces ... 2014 with regard to air-conditioning systems. Residential and ... for its incredibly hot summers. Working with an ... details of a wide variety of systems made ...
(Date:12/25/2014)... 26, 2014 The microscopy market ... 7.2% to reach $5,756.0 million by 2019. Optical ... market. The electron microscopes product segment is expected ... period. , Rising focus on nanotechnology, technological advancements, ... the microscopy market. , Get Full Copy of ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
(Date:12/24/2014)...  Since its launch in December 2014, the ... eliminate the pain of trying to remember their usernames ... own biometrics fused to their smartphones. To assist people ... Hoyos Labs , the company that created 1U and ... offering the app for free. 1U is ...
(Date:12/22/2014)... Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... security consultant, Apollo Robbins for the 2015 ... Apollo Robbins will be ... , 2015, demonstrating some of his famous theft techniques ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and ... announced the addition of the "The ... to their offering. ... provides an overview of the global digital ... to control and monitor piracy by securely ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4The Global Watermarking and Fingerprinting Markets 2
Other Contents